# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Psyence Biomedical Ltd (NASDAQ:PBM) ("Psyence Biomed" or the "Company") today announced that details of its upc...
The study, published in the journal Molecular Psychiatry, suggests that nature-derived psilocybin may be demonstrably more the...
Psyence Biomedical Ltd. (the "Company") (NASDAQ:PBM) announced that on March 11, 2024, it received two letters from the...